Key Updates: - HASHKEY HLDGS (03887) opens IPO subscription from Dec 9 to Dec 12, planning a global offering of 241 million shares with cornerstone investors including UBS AM Singapore. - SEYOND (02665) confirms listing on Dec 10 at HKD 10 per share. - FEDERAL PHARMA (03933) receives NMPA approval for Moxifloxacin Hydrochloride Eye Drops. - SHOUCHENG (00697) invests in DeepCloud Tech via Beijing Robotics Fund and Shoubao Fund. - PATEO (02889) selected as smart cockpit supplier for a leading OEM's next-gen NEV project. - GD-HKGBA H-2K (01396) subsidiary Tiandun Data signs strategic pact with Huagong Tech (000988.SZ).
Operational Performance: - CHINA LIFE (02628) reports YTD Nov premium income exceeding CNY 700 billion. - DATANG RENEW (01798) achieves 31.65TWh power generation in 11 months, up 10.58% YoY. - LONGHU (00960) records CNY 59.39 billion contracted sales Jan-Nov. - CHINA JINMAO (00817) posts CNY 100.68 billion sales, rising 21.3% YoY. - SEAPOWER (01030) sees 51.53% drop in sales to CNY 17.92 billion. - CIFI (00884) reports CNY 15.1 billion contracted sales.
Comments